Acomplia is one more example of how artificially influencing appetite signals, and thus leptin, is like playing with dynamite. Leptin is powerful, it controls survival. When drugs interact directly with subconscious brain circuitry associated with acquiring food, the result is highly unpredictable.">

FDA Ponders Weight Loss Drug that Increases Suicidal Thinking

June 12, 2007 | Byron J. Richards, Board Certified Clinical Nutritionist

Send to a friend

* Required fields

  or  Cancel

 FDA Ponders Weight Loss Drug that Increases Suicidal Thinking
Instead of pondering your next meal, now a person will be able to lose weight while pondering if they would like to live. Is the benefit worth the risk? Sanofi-Aventis's drug Acomplia is one more example of how artificially influencing appetite signals, and thus leptin, is like playing with dynamite. Leptin is powerful, it controls survival. When drugs interact directly with subconscious brain circuitry associated with acquiring food, the result is highly unpredictable.

It is nice that the FDA is warning in advance that the drug has serious psychiatric side-effects. The FDA even disclosed several people committed suicide during the drug's trials. Other problems include mood swings, anxiety and depression. Hopefully, the FDA will not allow this drug on the US market.

It is far easier to learn how to eat to be in harmony with leptin, at which time cravings for food disappear or are at least manageable. This is fully explained in my book, The Leptin Diet.

Search thousands of health news articles!